Honório Sampaio Menezes

Research

Fractional CO2 Laser in the Treatment of Post-Menopausal Vaginal Atrophy Fractional CO2 Laser in Post-Menopausal Women

Global Journal of Medical Research November 25, 2022

Introduction: Similarly to other parts of the body, the vagina changes over time, and vaginal atrophy is a common condition in women between 45 and 55 years of age. It causes discomfort and psychological suffering, in addition to being the main cause of pain during sexual intercourse. Objective: This study aimed to evaluate the use of intravaginal fractional CO2 laser in the treatment of atrophy of the vaginal mucosa, as well as its effect on symptoms such as itching, irritation, pain, dyspareunia, urinary incontinence, dryness, and loss of mucosal elasticity. Methods: This is a prospective cohort of 14 menopausal women with vulvovaginal symptoms who were evaluated pre- and post-procedure with CO2 laser treatment using the Monalisa Touch® technique. Cytological examination and validated questionnaires were used in the assessment.

Laparoscopic Superselective Transperitoneal Lumbar Sympathectomy for Treating Plantar Hyperhidrosis

Global Journal of Medical Research May 16, 2022

Retroperitoneoscopic lumbar sympathectomy is the standard surgical treatment for plantar hyperhidrosis. However, it is rarely performed due to the technical complexity of the procedure. This study aimed to describe a modified video-assisted lumbar sympathectomy technique, the superselective transperitoneal lumbar sympathectomy.

Traumatic Facial Injury Treated by Botulinum Toxin A

Global Journal of Medical Research May 16, 2022

Introduction: Botulinum toxin type A (BTA) is used in the treatment of various medical and aesthetic conditions. The mechanism of action of the drug includes action on fibroblast stimulation, decrease of wound tension and production of collagen. Objective: This study aimed to demonstrate the use of botulinum toxin as a possible treatment for reducing facial scarring. Methods: It was a retrospective study involving patients who were treated with BTA for the management of facial scars. Conclusion: Botulinum toxin A is efficient for the treatment and reduction of facial scars resulting from trauma or surgical interventions.

Show all 4 publications